Getinge AB ser. B Asset Resilience Ratio
Getinge AB ser. B asset resilience ratio. Getinge AB ser. B (GETI-B) has an Asset Resilience Ratio of 6.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Getinge AB ser. B fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Getinge AB ser. B (2008–2025)
Asset resilience ratio of Getinge AB ser. B from 2008 to 2025. This chart shows how Getinge AB ser. B's Asset Resilience Ratio has changed over time. Read how much debt does Getinge AB ser. B carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Getinge AB ser. B's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see GETI-B asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr3.40 Billion | 6.02% |
| Short-term Investments | Skr22.00 Million | 0.04% |
| Total Liquid Assets | Skr3.42 Billion | 6.06% |
Asset Resilience Insights
- Limited Liquidity: Getinge AB ser. B maintains only 6.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Getinge AB ser. B Industry Peers by Asset Resilience Ratio
Compare Getinge AB ser. B's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Getinge AB ser. B Asset Resilience Ratio by Year (2008–2025)
Getinge AB ser. B asset resilience ratio by year from 2008 to 2025. The table below shows the annual Asset Resilience Ratio data for Getinge AB ser. B.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.06% | Skr3.42 Billion ≈ $368.37 Million |
Skr56.51 Billion ≈ $6.08 Billion |
+1.38pp |
| 2024-12-31 | 4.67% | Skr2.99 Billion ≈ $321.45 Million |
Skr63.92 Billion ≈ $6.88 Billion |
-0.53pp |
| 2023-12-31 | 5.20% | Skr2.79 Billion ≈ $300.03 Million |
Skr53.59 Billion ≈ $5.77 Billion |
-5.84pp |
| 2022-12-31 | 11.05% | Skr5.75 Billion ≈ $618.47 Million |
Skr52.03 Billion ≈ $5.60 Billion |
+1.89pp |
| 2021-12-31 | 9.15% | Skr4.08 Billion ≈ $438.75 Million |
Skr44.55 Billion ≈ $4.79 Billion |
-8.93pp |
| 2020-12-31 | 18.08% | Skr8.14 Billion ≈ $875.67 Million |
Skr45.01 Billion ≈ $4.84 Billion |
+15.25pp |
| 2019-12-31 | 2.83% | Skr1.27 Billion ≈ $136.24 Million |
Skr44.71 Billion ≈ $4.81 Billion |
-0.14pp |
| 2018-12-31 | 2.98% | Skr1.29 Billion ≈ $138.82 Million |
Skr43.35 Billion ≈ $4.67 Billion |
-1.05pp |
| 2017-12-31 | 4.03% | Skr1.70 Billion ≈ $182.52 Million |
Skr42.10 Billion ≈ $4.53 Billion |
+0.68pp |
| 2016-12-31 | 3.34% | Skr1.85 Billion ≈ $198.66 Million |
Skr55.21 Billion ≈ $5.94 Billion |
+3.05pp |
| 2015-12-31 | 0.30% | Skr158.00 Million ≈ $17.00 Million |
Skr53.23 Billion ≈ $5.73 Billion |
-0.20pp |
| 2014-12-31 | 0.50% | Skr264.00 Million ≈ $28.41 Million |
Skr52.82 Billion ≈ $5.68 Billion |
-0.58pp |
| 2013-12-31 | 1.08% | Skr480.00 Million ≈ $51.66 Million |
Skr44.30 Billion ≈ $4.77 Billion |
+0.46pp |
| 2012-12-31 | 0.62% | Skr267.00 Million ≈ $28.73 Million |
Skr42.92 Billion ≈ $4.62 Billion |
-0.55pp |
| 2010-12-31 | 1.17% | Skr405.00 Million ≈ $43.58 Million |
Skr34.59 Billion ≈ $3.72 Billion |
+0.35pp |
| 2009-12-31 | 0.82% | Skr307.00 Million ≈ $33.04 Million |
Skr37.50 Billion ≈ $4.04 Billion |
+0.54pp |
| 2008-12-31 | 0.28% | Skr92.00 Million ≈ $9.90 Million |
Skr33.03 Billion ≈ $3.55 Billion |
-- |
About Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solu… Read more